ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 670969 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 670969; 2) Community: the network communities that were significantly associated with the response to NSC 670969; 3) Molecule: the relationships between components within communities and NSC 670969; 4) MDR: the compounds that were significantly associated with the NSC 670969.

NSC Compound Enrichment Correlation
NSC 635449 Copper, chloro[2-[1-(2-pyridinyl)ethylidene][N,N-dipropyl-hydrazinecarbothioamidato-N,N,S]- 0.0147237897640499 0.66886972
NSC 639520 Cyclohexanone, 2-[(2-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.0147237897640499 0.6311461
NSC 639541 Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- 0.0147237897640499 0.62222926
NSC 670784 Null 0.0147237897640499 0.67582411
NSC 683556 Camptothecin Derivative 0.0147237897640499 0.24332047
NSC 643724 Null 0.0176693828663435 -0.43458183
NSC 677666 Null 0.0176693828663438 0.30002399
NSC 696660 (6R,6S)-2,4-Diamino-6-(3,4-dimethoxybenzyl)-5,6,7,8-tetrahydroquinazoline 0.0176693828663438 -0.0069330787
NSC 720725 Null 0.0176693828663438 0.0054912081
NSC 726195 2-phenyl 3-[(6-ethyl, 4-amino, 5-(4-chlorophenyl) pyrimidin-2-yl)] quinazolin-4-one 0.0176693828663438 0.17629934
Total:119  Current:53    [First] [Prev] [Next] [Last]